GOOD distribution PRACTICE

Good Distribution Practice (GDP) is that part of quality assurance that ensures that the quality of a pharmaceutical product is maintained through adequate control throughout the numerous activities which occur during the distribution process.

Good Distribution Practices

what are the benefits of GOOD DISTRIBUTION PRACTICES?

  • Ensures principles of GDP are applied throughout the supply chain
  • Maintains product integrity and patient safety
  • Helps achieve consistency
  • Reduces the risk of falsified medicines entering the supply chain
  • Reduces distribution complaints
  • Improves customer confidence
  • Reduces expensive mistakes
  • Improves efficiency and lower costs
  • Reduces wastage
  • Improves margins
  • Creates a culture of continual improvement
  • Increases market share
  • Involves, motivates and assists in the training of staff
  • Helps market the organisation effectively
  • Puts the organisation in a position to exploit new market sectors and territories


The implementation and certification of Good Distribution Practice is of paramount importance to safety as the global supply chain is becoming more complex and fragmented specifically in the pharmaceutical industry and food processing and packaging industry.

What are the requirements of GOOD DISTRIBUTION PRACTICES?

  1. Quality System through Risk Management and Quality Review
  • QRM is a systematic process for identification, understanding, assessment and review of risks to the quality of the products manufactured.
  • Regular and periodic quality reviews of all products should be performed with the objective of verification and consistent practices of existing processes.
  1. Warehousing and Storage
  • Define policies and procedures to maintain storage standards where pharmaceutical and food products are stored.
  1. Transportation and Distribution
  • Procedures to deliver pharmaceutical or food products need to be defined w.r.t handling of such specific products that are in terms of applicable national, regional and

international legislation.

  • Written procedures for the dispatch of pharmaceutical products should be established and its traceability process must be defined.
  1. Complaints and Product Recalls
  • Complaints and other related information concerning potential defective products should be reviewed according to written procedures.

Get In Touch 

have a question? let us get back to you.